Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 322 (ZNF322) is a transcriptional activator and a member of the C2H2-type zinc finger transcription factor family. It promotes gene transcription and is involved in positive regulation of stem cell maintenance, pluripotency, and embryonic heart development through regulation of MAPK signaling pathways. ZNF322 binds directly to promoters and enhancers of key pluripotency factors such as POU5F1 and NANOG, influencing expression levels and stem cell fate decisions. It is expressed widely in adult and developing human tissues, and localizes to the nucleus and cytoplasm. Currently, ZNF322 is recognized for its role in transcriptional regulation rather than as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 322 (ZNF322).